Introducing Clarins’ Revolutionary Double Serum Eye: The Future of Youthful Eyes
Renowned French skincare brand, Clarins, has launched its most innovative eye treatment yet — the Double Serum Eye. This product is the culmination of 30 years of longevity science and seven years of pioneering epigenetics research. Unveiled on July 9, 2026, this reimagined serum addresses both chronological aging and lifestyle-related epigenetic aging, marking a groundbreaking first in the eye-care industry.
The unique aspect of this launch is Clarins’ proprietary twin-chamber technology. This two-phase formula combines a hydric serum (2/3) and a hydrolipidic emulsion (1/3), mirroring the skin’s natural composition. The two elements merge into one powerful drop at the moment of application.
At the core of the formula is Organic Marjoram Extract, which has been proven to neutralize up to 98% of lifestyle-related epigenetic changes in vitro. This is coupled with the iconic Turmeric to combat chronological aging by enhancing the skin’s five vital functions. The serum, further enhanced by 96% natural-origin ingredients, also includes Niacinamide to diminish hyperpigmentation and Horse Chestnut Escin to reduce dark circles.
In a unique twin study, Clarins researchers discovered that epigenetic aging alone can make the eye contour appear up to four years older. This finding provides a compelling incentive for consumers to take early action. The new Double Serum Eye will be available exclusively on Clarins.com and at nationwide retailers this August.
Source: PRNewswire – Clarins Double Serum Eye Launch, July 9, 2026